Home > Packaging > Industrial Packaging > Pharmaceutical Packaging > Vaccine Packaging Market
The global vaccine packaging market was valued at USD 1.8 billion in 2023 and is estimated to grow at a CAGR of 10.4% from 2024 to 2032.
The vaccine packaging industry is experiencing growth due to several key factors. Global vaccination initiatives, supported by governments and health organizations, are increasing demand for advanced packaging solutions. These solutions must ensure vaccine safety, efficacy, and compliance with strict regulatory standards. Technological advancements in packaging materials, including smart packaging with monitoring capabilities, are improving vaccine integrity during storage and distribution.
The rise of biologics and complex vaccines requires specialized packaging designs for stability and extended shelf life. Sustainability concerns are influencing the market, with a focus on eco-friendly materials and waste reduction. The COVID-19 pandemic has highlighted the importance of efficient and scalable vaccine packaging solutions, leading to accelerated innovation and market expansion to meet increased healthcare needs. For instance, January 2024, SCHOTT Pharma launched the EVERIC freeze vials, specifically designed for the deep-cold storage of pharmaceuticals, including mRNA vaccines and gene therapies. These vials can withstand storage temperatures as low as -80°C, addressing the challenges posed by the freezing and thawing processes that often lead to glass breakage in conventional vials.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Vaccine Packaging Market Size in 2023: | USD 1.8 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 10.4% |
2032 Value Projection: | USD 4.4 Billion |
Historical Data for: | 2021 - 2023 |
No. of Pages: | 280 |
Tables, Charts & Figures: | 320 |
Segments covered: | Product, Type, Material, End User |
Growth Drivers: |
|
Pitfalls & Challenges: |
|